How would you approach a patient with metastatic chordoma with leptomeningeal spread involving multiple nodules and a dominant cervical spine lesion causing motor weakness?

Community
Company
News
Contact Us
Sign in

Topics: Radiation Oncology • Neuro-Oncology

What dosage, target volume, and fractionation would you use? Role for CSI? Role for surgery?

Related Questions

Would you manage a subtotally resected pilocytic astrocytoma with deleted CDKN2A differently than one with intact CDKN2A?

How would you manage a patient with brain metastases treated with FSRT that inadvertently continued Alectinib during treatment?

How do you proceed with radiation planning for preliminary suspected high grade gliomas after surgery when there is a delay in final molecular diagnosis?

What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?

How would you approach a patient over the age of 40 with a sub-totally resected frontal oligodendroglioma, WHO Grade II, 1p/19q co-deleted, IDH mutant, with imaging concerning for second site in the pontomedullary junction?

How would you treat grade 3 cauda equina meningioma status post biopsy only with a history of prior prostate/whole pelvis radiation?

What dose, constraints, and technical parameters would you use for a SIB FSRT plan for a large brain metastasis resection cavity with rapid interval tumor growth along periphery of the resection cavity?

How do you use Boswellia for radiation necrosis?

Would you offer post-operative radiation for a glomus tumor of the spine following decompressive laminectomy and incomplete resection?

What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?